ECSP17012504A - Uso de un producto de arcilla o un producto de mezcla de arcilla para disminuir los efectos de enfermedad bacteriana en camarones - Google Patents

Uso de un producto de arcilla o un producto de mezcla de arcilla para disminuir los efectos de enfermedad bacteriana en camarones

Info

Publication number
ECSP17012504A
ECSP17012504A ECIEPI201712504A ECPI201712504A ECSP17012504A EC SP17012504 A ECSP17012504 A EC SP17012504A EC IEPI201712504 A ECIEPI201712504 A EC IEPI201712504A EC PI201712504 A ECPI201712504 A EC PI201712504A EC SP17012504 A ECSP17012504 A EC SP17012504A
Authority
EC
Ecuador
Prior art keywords
clay
product
effects
shrimp
clostridium
Prior art date
Application number
ECIEPI201712504A
Other languages
English (en)
Inventor
San Ching
Ron Cravens
Fang Chi
Original Assignee
Collecte Localisation Satellites
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Collecte Localisation Satellites filed Critical Collecte Localisation Satellites
Publication of ECSP17012504A publication Critical patent/ECSP17012504A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Los Solicitantes han examinado dos especies de Clostridium, Clostridium difficile y Clostridium perfringens, y encontraron que las arcillas pueden adsorber la toxina producida por ambas y que un producto mezclado de arcilla puede disminuir los efectos de una afección prominente en pollos y conocida como Enteritis Crónica, que es causada por C. perfringens. Recientemente una arcilla o una mezcla de arcilla que puede ser una combinación de arcilla, levadura y una forma de un aminoácido funcional, se examinó y se encontró que ayuda a disminuir los efectos de la enfermedad de necrosis hepatopancreática aguda (AHPND) que también es conocida como Síndrome de Mortalidad Temprana (EMS) en camarones cuando se utilizó un modelo de estimulación que incluyó Vibrio parahaemolyticus.
ECIEPI201712504A 2014-08-01 2017-02-24 Uso de un producto de arcilla o un producto de mezcla de arcilla para disminuir los efectos de enfermedad bacteriana en camarones ECSP17012504A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462032238P 2014-08-01 2014-08-01

Publications (1)

Publication Number Publication Date
ECSP17012504A true ECSP17012504A (es) 2017-05-31

Family

ID=55218385

Family Applications (1)

Application Number Title Priority Date Filing Date
ECIEPI201712504A ECSP17012504A (es) 2014-08-01 2017-02-24 Uso de un producto de arcilla o un producto de mezcla de arcilla para disminuir los efectos de enfermedad bacteriana en camarones

Country Status (4)

Country Link
CN (1) CN107106597A (es)
EC (1) ECSP17012504A (es)
MX (1) MX2017001426A (es)
WO (1) WO2016019343A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2906238B1 (en) * 2012-10-02 2020-07-08 Oil-Dri Corporation of America Clay product and uses thereof
US11135561B2 (en) * 2016-12-22 2021-10-05 Firmenich Sa Microcapsules having a mineral layer
JP2019055943A (ja) * 2017-09-19 2019-04-11 ネオファーマジャパン株式会社 ５−アミノレブリン酸を含むエビ目用組成物
CN110547359B (zh) * 2019-08-29 2022-07-26 清远海贝生物技术有限公司 一种虾用抗肠道弧菌保健料

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007011825A2 (en) * 2005-07-19 2007-01-25 Texas Enterosorbent, Inc. Preservative and additive for food and feed
WO2010028215A1 (en) * 2008-09-05 2010-03-11 Mionix Corporation Antimicrobial fish and shrimp feed
EP2906238B1 (en) * 2012-10-02 2020-07-08 Oil-Dri Corporation of America Clay product and uses thereof

Also Published As

Publication number Publication date
CN107106597A (zh) 2017-08-29
WO2016019343A1 (en) 2016-02-04
MX2017001426A (es) 2017-08-02

Similar Documents

Publication Publication Date Title
BR112015022191A2 (pt) compostos heteroarila, seu uso e composição que os compreende
CL2015003731A1 (es) Inhibidores de bromodominios
BR112019001607A2 (pt) inibidores macrocíclicos de quinases
CL2015003117A1 (es) Modificaciones en la estructura cristalina
BR112017008659A2 (pt) ?métodos e compostos de agonista de gip?
ECSP17012504A (es) Uso de un producto de arcilla o un producto de mezcla de arcilla para disminuir los efectos de enfermedad bacteriana en camarones
BR112015021888A8 (pt) inibidores de dna-pk, seus usos e composição farmacêutica
BR112015020389A2 (pt) compostos carbazol úteis como inibidores de bromodomínio
ES2838803T3 (es) Método para reducir la producción total de gas y/o la producción de metano en un animal rumiante
GT201400147A (es) Pirimidinas y triazinas fusionadas sustituidas y su uso
CL2015002677A1 (es) Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o condiciones asociadas con la disfunción mitocondrial.
IN2015DN03322A (es)
NZ606589A (en) 5-chloro-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide, salts and uses thereof
UY35693A (es) Pirazolo[1,5-a]piridin-3-carboxamidas sustituidas y su uso
AR103077A1 (es) Método para la producción de un sistema de administración farmacéutica
BR112016029894A2 (pt) método para aumentar o ganho de peso e/ou melhorar a razão de corversão de alimentos de animais de fazenda, e, uso de uma ou mais enzimas protolíticas em combinação com pelo menos uma fitase no alimento para animais.
MX2015010003A (es) Triterpenoides c-19 modificados, con actividad inhibidora de la maduracion del virus de inmunodeficiencia humana (vih).
EA201692313A1 (ru) Производные индолизина в качестве ингибиторов фосфоинозитид-3-киназ
BR112017005660A2 (pt) novos ativadores de guanilato ciclase solúvel e sua utilização
CL2015002835A1 (es) Nuevos derivados de piridina
UA117032C2 (uk) Селективний інгібітор фосфатидилінозитол-3-кінази-гамма
WO2014106825A3 (en) Methods and devices for identifying improper medical reporting
DOP2016000297A (es) Composiciones farmacéuticas útiles para tratar enfermedades infecciosas
EA201401117A1 (ru) Композиции, содержащие пробиотики и комплекс пчелиной пыльцы/глины, способ их приготовления и их применение в питании и терапии
AR099766A1 (es) Inhibidores de la quinasa asociada al adaptador 1, composiciones que los comprenden y métodos para utilizarlos